NEW STEP BY STEP MAP FOR HEMGENIX

Number of suitable people: CDEC discussed the uncertainty in the number of patients with reasonably critical to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some individuals who're classified as having moderate or average sickness may have a significant bleeding phe